Bilateral ipilimumab-induced posterior uveitis following treatment for metastatic choroidal melanoma

Clin Exp Ophthalmol. 2018 Sep;46(7):819-821. doi: 10.1111/ceo.13197. Epub 2018 Apr 25.

Authors

Alexander Xj Tan¹, Amelia Ang², William G Campbell², David Ca Fabinyi²

Affiliations

¹ Vitreoretinal Unit, The Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
² Cancer Clinical Trials Unit, The Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.

PMID: 29653019
DOI: 10.1111/ceo.13197

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents, Immunological / adverse effects
Antineoplastic Agents, Immunological / therapeutic use
Brachytherapy
Choroid Neoplasms / pathology*
Choroid Neoplasms / therapy
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Ipilimumab / adverse effects*
Ipilimumab / therapeutic use
Male
Melanoma / secondary*
Melanoma / therapy
Tomography, Optical Coherence
Uveitis, Posterior / chemically induced*
Uveitis, Posterior / diagnosis

Substances

Antineoplastic Agents, Immunological
Ipilimumab